Advertisement

Topics

Octapharma Company Profile

22:55 EDT 22nd June 2018 | BioPortfolio

Octapharma, a Swiss-based company, is an independent, global plasma fractionation specialist. Its core business is the development, production and sale of high quality plasma derivatives.From its foundation in 1983 the company has grown to employ over 1482 people in 27 countries. Octapharma owns four modern, state-of-the-art production facilities in Austria, France, Sweden and Mexico. Since 2005 Octapharma also opperates the NSTOB plant in Springe Germany. Sales turnover in 2005 exceeded Euro 421 million

Location

Switzerland


News Articles [23 Associated News Articles listed on BioPortfolio]

Octapharma present new data on the benefits of Nuwiq® in patients with haemophilia A at the ...

Octapharma AGInternational Business Unit - HaematologyOlaf WalterOlaf.Walter@octapharma.comorLarisa BelyanskayaLarisa.Belyanskaya@octapharma.comTel: +41 55 4512121 Read more....

Octapharma Share Promising Preclinical Data for SubQ-8, a Novel Subcutaneous Recombinant FVIII, ...

Octapharma AGInternational Business Unit - HaematologyOlaf WalterOlaf.Walter@octapharma.comorLarisa BelyanskayaLarisa.Belyanskaya@octapharma.comTel: +41 55 4512121 Read more....

Octapharma Group Publishes 2017 Annual Results Reporting Revenue of €1. ...

Octapharma AGClaudie QumsiehCorporate Communications ManagerOffice: +41 55 4512 121claudie.qumsieh@octapharma.com Read more...

Octapharma Group Publishes 2017 Annual Results Reporting Revenue of €1.72 Billion and Operating Income of €349 Million

Over the last six years, the Octapharma Group has accomplished a remarkable compound annual growth rate of 15% and reports another record-breaking result for 2017, with sales of ...

Octapharma Support Enables Bombardier to Climb Mount Vinson, Becoming First Hemophiliac to Ascend the Seven Summits

Octapharma Partnership with Mountain Climber will Culminate with Release of Documentary Bombardier Blood Later this Year Mountain climber Chris Bombardier of Denver, Co...

Chris Bombardier, First Hemophiliac to Climb the Seven Summits, Joins Octapharma USA at HFA Annual Symposium in Cleveland

Mountain Climber Will Discuss Mount Everest Climb, Upcoming Documentary One-on-One With Visitors of Octapharma Booth Hemophilia hero Chris Bombardier, who recently beca...

Octapharma: Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A

Octapharma is delighted to announce the publication of final data from a Good Clinical Practice (GCP) trial in PUPs in the internationally renowned medical journal Haemophilia. Th...

Octapharma USA Grant Supports National Conference for Type 3 von Willebrand Disease Patients

‘Making the Connection’ will be held June 22 – 25 in Palm Beach Gardens, Florida For the second year in a row, Octapharma USA will serve as the exclusive sponsor ...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Albumin (human) [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.]

These highlights do not include all the information needed to use ALBUMIN (HUMAN) 5% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 5%. ALBUMIN (HUMAN) 5% For intravenous...

Albumin (human) [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.]

These highlights do not include all the information needed to use ALBUMIN (HUMAN) 20% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 20%. ALBUMIN (HUMAN) 20% For intraven...

Albumin (human) [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.]

These highlights do not include all the information needed to use ALBUMIN (HUMAN) 25% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 25%. ALBUMIN (HUMAN) 25% For intraven...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study.

Intravenous immunoglobulin (IVIG) therapy is commonly used to treat patients with primary antibody deficiency. This prospective, open-label, non-randomised, multicentre, phase III trial investigated t...

Clinical Trials [0 Results]

None

Companies [7 Associated Companies listed on BioPortfolio]

Octapharma AG

Octagam®10% is a liquid, 10% (100 mg/mL) immune globulin (human) solution for intravenous administration (IVIG) which is currently registered in European countries and expected...

Octapharma USA

Headquartered in Lachen, Switzerland, Octapharma is one of the largest plasma products manufacturers in the world and has been committed to patient care and medical innovation for over 25 years. Octap...

Octapharma Group

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and huma...

Octapharma

Octapharma, a Swiss-based company, is an independent, global plasma fractionation specialist. Its core business is the development, production and sale of high quality plasma derivatives.From its foun...

Octapharma USA, Inc

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovat...

More Information about "Octapharma" on BioPortfolio

We have published hundreds of Octapharma news stories on BioPortfolio along with dozens of Octapharma Clinical Trials and PubMed Articles about Octapharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Octapharma Companies in our database. You can also find out about relevant Octapharma Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record